Folate Metabolism–Based Risk Stratification Identifies CYP27B1 as a Determinant of Tumor Progression in HNSCC - Quiz - MDSpire

Folate Metabolism–Based Risk Stratification Identifies CYP27B1 as a Determinant of Tumor Progression in HNSCC

  • By

  • Kai, Zhang

  • Hu, Haixia

  • Liu, Bingya

  • April 21, 2026

  • 0 min

Share

Original Source(s)

Folate Metabolism–Based Risk Stratification Identifies CYP27B1 as a Determinant of Tumor Progression in HNSCC

  • by Kai, Zhang , Hu, Haixia , Liu, Bingya

  • April 21, 2026

Related Content

Potential targets for boron transport in boron neutron capture therapy

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma